PTEN and cancer: Thus, despite the fact that PTEN inactivation through PTEN mutation or deletion is infrequent in pancreatic cancer, we raise the hypothesis that TGF-β1 overexpression may lead to reduced PTEN mRNA levels in pancreatic cancers which may give these cells an additional growth advantage and, thus, contributes to the aggressive phenotype of this cancer.